Scienture Holdings, Inc. carries a market capitalization of 6.03M, placing it among publicly traded companies globally. Its enterprise value stands at 3.47M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 6.03M |
| Enterprise Value | 3.47M |
Scienture Holdings, Inc. currently has 40.63M shares outstanding.
| Shares Outstanding | 40.63M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
The price-to-sales ratio is 14.66, and the price-to-book ratio stands at -0.08.
| PE Ratio | N/A |
| PS Ratio | 14.66 |
| PB Ratio | -0.08 |
| P/TBV Ratio | -1.89 |
| P/FCF Ratio | -0.52 |
| P/OCF Ratio | -0.52 |
| EV / Sales | 7.27 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | N/A |
Scienture Holdings, Inc. maintains a current ratio of 1.70, meaning it holds 1.7x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 0.01, indicating conservative leverage, while an interest coverage ratio of -4.42 demonstrates limited ability to service its debt obligations.
| Current Ratio | 1.70 |
| Quick Ratio | 1.52 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.00 |
| Interest Coverage | -4.42 |
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -44.76 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 0.88 |
| Income Tax | -1.99M |
| Effective Tax Rate | N/A |
Scienture Holdings, Inc.'s stock has declined approximately -53.62989% over the past 52 weeks. The 50-day moving average sits at 0.39, while the 200-day moving average is 0.60.
| Beta (5Y) | N/A |
| 52-Week Price Change | -53.62989% |
| 50-Day Moving Average | 0.39 |
| 200-Day Moving Average | 0.60 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Scienture Holdings, Inc. generated 477,676.00 in revenue and converted that into -41.85M in net income, yielding earnings per share of -1.70. EBITDA reached -15.24M, while operating income came in at -16.18M.
| Revenue | 477,676.00 |
| Gross Profit | 384,659.00 |
| Operating Income | -16.18M |
| Pretax Income | -43.85M |
| Net Income | -41.85M |
| EBITDA | -15.24M |
| EBIT | -16.18M |
| Earnings Per Share (EPS) | -1.70 |
Scienture Holdings, Inc. holds 3.54M in cash and equivalents against 10,004.00 in total debt, resulting in a net debt position of -3.54M. Total book value stands at -83.95M, with working capital of 1.97M providing operational flexibility.
| Cash & Cash Equivalents | 3.54M |
| Total Debt | 10,004.00 |
| Net Debt | -3.54M |
| Equity (Book Value) | -83.95M |
| Book Value Per Share | -3.42 |
| Working Capital | 1.97M |
Scienture Holdings, Inc. produced -13.34M in operating cash flow over the past twelve months.
| Operating Cash Flow | -13.34M |
| Capital Expenditures | N/A |
| Free Cash Flow | -13.34M |
| FCF Per Share | -0.54 |
Scienture Holdings, Inc. operates with a gross margin of 80.53, reflecting its pricing power and cost economics. The operating margin of -3,387.86 and net profit margin of -8,761.28 provide insight into operational efficiency.
| Gross Margin | 80.53 |
| Operating Margin | -3,387.86 |
| Pretax Margin | -9,178.90 |
| Profit Margin | -8,761.28 |
| EBITDA Margin | -3,190.07 |
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -211.81 |
| FCF Yield | -190.49 |
Scienture Holdings, Inc.'s most recent stock split took place on June 22, 2023 with a 15:1 split ratio.
| Last Split Date | 6/22/2023 |
| Split Ratio | 15:1 |
Scienture Holdings, Inc. posts an Altman Z-Score of -16.27, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -16.27 |